Interactions between FGF21 and BMP-2 in osteogenesis

Biochemical and Biophysical Research Communications

Volumn 432, Issue 4, 2013, Pages 677-682

  Ishida, Kazunari ^a   Haudenschild, Dominik R ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone morphogenic protein 2; Fibroblast growth factor 21; Osteogenesis; Smad pathway

Indexed keywords

ALKALINE PHOSPHATASE; BONE MORPHOGENETIC PROTEIN 2; FIBROBLAST GROWTH FACTOR 21; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 3; SMAD PROTEIN; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; BONE MINERALIZATION; CONTROLLED STUDY; GENE EXPRESSION; IN VITRO STUDY; INTRACELLULAR SIGNALING; MOUSE; NEGATIVE FEEDBACK; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION;

BONE MORPHOGENETIC PROTEIN 2; CELL LINE; CHONDROCYTES; FIBROBLAST GROWTH FACTORS; GENE EXPRESSION REGULATION; HUMANS; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; OSTEOGENESIS; PHOSPHORYLATION; SMAD1 PROTEIN; SMAD5 PROTEIN; SMAD8 PROTEIN; TRANSCRIPTION, GENETIC;

EID: 84875543830     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2013.02.019     Document Type: Article

References (35)

1. McKay W.F., Peckham S.M., Badura J.M. A comprehensive clinical review of recombinant human bone morphogenetic protein-2 (INFUSE Bone Graft). Int. Orthop. 2007, 31:729-734.
2. Ishida K., Matsumoto T., Sasaki K., Mifune Y., Tei K., Kubo S., Matsushita T., Takayama K., Akisue T., Tabata Y., Kurosaka M., Kuroda R. Bone regeneration properties of granulocyte colony-stimulating factor via neovascularization and osteogenesis. Tissue Eng. Part A 2010, 16:3271-3284.
3. Wozney J.M., Rosen V., Celeste A.J., Mitsock L.M., Whitters M.J., Kriz R.W., Hewick R.M., Wang E.A. Novel regulators of bone formation: molecular clones and activities. Science 1988, 242:1528-1534.
4. Beenken A., Mohammadi M. The FGF family: biology, pathophysiology and therapy. Nat. Rev. Drug Discov. 2009, 8:235-253.
5. Kubota K., Iseki S., Kuroda S., Oida S., Iimura T., Duarte W.R., Ohya K., Ishikawa I., Kasugai S. Synergistic effect of fibroblast growth factor-4 in ectopic bone formation induced by bone morphogenetic protein-2. Bone 2002, 31:465-471.
6. Mayahara H., Ito T., Nagai H., Miyajima H., Tsukuda R., Taketomi S., Mizoguchi J., Kato K. In vivo stimulation of endosteal bone formation by basic fibroblast growth factor in rats. Growth Factors 1993, 9:73-80.
7. Naganawa T., Xiao L., Coffin J.D., Doetschman T., Sabbieti M.G., Agas D., Hurley M.M. Reduced expression and function of bone morphogenetic protein-2 in bones of FGF2 null mice. J. Cell. Biochem. 2008, 103:1975-1988.
8. Liu C., Goswami M., Talley J., Chesser-Martinez P.L., Lou C.H., Sater A.K. TAK1 promotes BMP4/Smad1 signaling via inhibition of erk MAPK: a new link in the FGF/BMP regulatory network. Differentiation 2012, 83:210-219.
9. Hogan B.L. Morphogenesis. Cell 1999, 96:225-233.
10. Zilberberg L., ten Dijke P., Sakai L.Y., Rifkin D.B. A rapid and sensitive bioassay to measure bone morphogenetic protein activity. BMC Cell Biol. 2007, 8:41.
11. Blau H.M., Pavlath G.K., Hardeman E.C., Chiu C.P., Silberstein L., Webster S.G., Miller S.C., Webster C. Plasticity of the differentiated state. Science 1985, 230:758-766.
12. Katagiri T., Yamaguchi A., Komaki M., Abe E., Takahashi N., Ikeda T., Rosen V., Wozney J.M., Fujisawa-Sehara A., Suda T. Bone morphogenetic protein-2 converts the differentiation pathway of C2C12 myoblasts into the osteoblast lineage. J. Cell Biol. 1994, 127:1755-1766.
13. Zhu W., Boachie-Adjei O., Rawlins B.A., Frenkel B., Boskey A.L., Ivashkiv L.B., Blobel C.P. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J. Biol. Chem. 2007, 282:18676-18685.
14. Ito Y., Fukushima H., Katagiri T., Seo Y., Hirata S., Zhang M., Hosokawa R., Jimi E. Lactacystin, a proteasome inhibitor, enhances BMP-induced osteoblastic differentiation by increasing active Smads. Biochem. Biophys. Res. Commun. 2011, 407:225-229.
15. Maeda T., Matsunuma A., Kurahashi I., Yanagawa T., Yoshida H., Horiuchi N. Induction of osteoblast differentiation indices by statins in MC3T3-E1 cells. J. Cell. Biochem. 2004, 92:458-471.
16. Adams A.C., Coskun T., Rovira A.R., Schneider M.A., Raches D.W., Micanovic R., Bina H.A., Dunbar J.D., Kharitonenkov A. Fundamentals of FGF19 & FGF21 action in vitro and in vivo. PLoS One 2012, 7:e38438.
17. Hulejova H., Cerezo L.A., Kuklova M., Pecha O., Vondracek T., Pavelka K., Vencovsky J., Haluzik M., Senolt L. Novel adipokine fibroblast growth factor 21 is increased in rheumatoid arthritis. Physiol. Res. 2012, 61:489-494.
18. Kotulak T., Drapalova J., Kopecky P., Lacinova Z., Kramar P., Riha H., Netuka I., Maly J., Housa D., Blaha J., Svacina S., Haluzik M. Increased circulating and epicardial adipose tissue mRNA expression of fibroblast growth factor-21 after cardiac surgery: possible role in postoperative inflammatory response and insulin resistance. Physiol. Res. 2011, 60:757-767.
19. Huang C.Y., Lee C.Y., Chen M.Y., Tsai H.C., Hsu H.C., Tang C.H. Adiponectin increases BMP-2 expression in osteoblasts via AdipoR receptor signaling pathway. J. Cell. Physiol. 2010, 224:475-483.
20. Strotmeyer E.S., Cauley J.A. Diabetes mellitus, bone mineral density, and fracture risk. Curr. Opin. Endocrinol. Diabetes Obes. 2007, 14:429-435.
21. Hernandez R.K., Do T.P., Critchlow C.W., Dent R.E., Jick S.S. Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database. Acta Orthop. 2012, 83:653-660.
22. Schedlich L.J., Flanagan J.L., Crofts L.A., Gillies S.A., Goldberg D., Morrison N.A., Eisman J.A. Transcriptional activation of the human osteocalcin gene by basic fibroblast growth factor. J. Bone Miner. Res. 1994, 9:143-152.
23. Mansukhani A., Bellosta P., Sahni M., Basilico C. Signaling by fibroblast growth factors (FGF) and fibroblast growth factor receptor 2 (FGFR2)-activating mutations blocks mineralization and induces apoptosis in osteoblasts. J. Cell Biol. 2000, 149:1297-1308.
24. Huang Z., Ren P.G., Ma T., Smith R.L., Goodman S.B. Modulating osteogenesis of mesenchymal stem cells by modifying growth factor availability. Cytokine 2010, 51:305-310.
25. Maegawa N., Kawamura K., Hirose M., Yajima H., Takakura Y., Ohgushi H. Enhancement of osteoblastic differentiation of mesenchymal stromal cells cultured by selective combination of bone morphogenetic protein-2 (BMP-2) and fibroblast growth factor-2 (FGF-2). J. Tissue Eng. Regen. Med. 2007, 1:306-313.
26. Hanada K., Dennis J.E., Caplan A.I. Stimulatory effects of basic fibroblast growth factor and bone morphogenetic protein-2 on osteogenic differentiation of rat bone marrow-derived mesenchymal stem cells. J. Bone Miner. Res. 1997, 12:1606-1614.
27. Inagaki T., Lin V.Y., Goetz R., Mohammadi M., Mangelsdorf D.J., Kliewer S.A. Inhibition of growth hormone signaling by the fasting-induced hormone FGF21. Cell Metab. 2008, 8:77-83.
28. Wei W., Dutchak P.A., Wang X., Ding X., Bookout A.L., Goetz R., Mohammadi M., Gerard R.D., Dechow P.C., Mangelsdorf D.J., Kliewer S.A., Wan Y. Fibroblast growth factor 21 promotes bone loss by potentiating the effects of peroxisome proliferator-activated receptor gamma. Proc. Natl. Acad. Sci. USA 2012, 109:3143-3148.
29. Zhang W., Liu H.T. MAPK signal pathways in the regulation of cell proliferation in mammalian cells. Cell Res. 2002, 12:9-18.
30. Johnson C.L., Weston J.Y., Chadi S.A., Fazio E.N., Huff M.W., Kharitonenkov A., Koester A., Pin C.L. Fibroblast growth factor 21 reduces the severity of cerulein-induced pancreatitis in mice. Gastroenterology 2009, 137:1795-1804.
31. Wu S., Levenson A., Kharitonenkov A., De Luca F. Fibroblast growth factor 21 (FGF21) inhibits chondrocyte function and growth hormone action directly at the growth plate. J. Biol. Chem. 2012, 287:26060-26067.
32. Kliewer S.A., Mangelsdorf D.J. Fibroblast growth factor 21: from pharmacology to physiology. Am. J. Clin. Nutr. 2010, 91:254S-257S.
33. Kharitonenkov A., Shiyanova T.L., Koester A., Ford A.M., Micanovic R., Galbreath E.J., Sandusky G.E., Hammond L.J., Moyers J.S., Owens R.A., Gromada J., Brozinick J.T., Hawkins E.D., Wroblewski V.J., Li D.S., Mehrbod F., Jaskunas S.R., Shanafelt A.B. FGF-21 as a novel metabolic regulator. J. Clin. Invest. 2005, 115:1627-1635.
34. Loeffler I., Hopfer U., Koczan D., Wolf G. Type VIII collagen modulates TGF-beta1-induced proliferation of mesangial cells. J. Am. Soc. Nephrol. 2011, 22:649-663.
35. Hayashi H., Ishisaki A., Suzuki M., Imamura T. BMP-2 augments FGF-induced differentiation of PC12 cells through upregulation of FGF receptor-1 expression. J. Cell Sci. 2001, 114:1387-1395.